Sarcopenia is an important extrapulmonary manifestation of chronic obstructive pulmonary disease (COPD), contributing to reduced physical function and adverse clinical outcomes. Updated Asian Working Group for Sarcopenia (AWGS) 2025 criteria provide a framework for its assessment. Chest computed tomography (CT) enables evaluation of skeletal muscle quantity and quality, offering additional prognostic information. Particularly, reduced erector spinae muscle density, reflecting intramuscular fat accumulation, is associated with loss of health-related independence, in patients with normal body weight. Recent studies have also demonstrated an association between airway mucus plugging and sarcopenia in COPD. Greater mucus plug burden is associated with reduced exercise capacity, skeletal muscle mass, and fat mass, suggesting potential interactions between pulmonary and systemic impairment. These findings highlight the importance of comprehensive assessment beyond airflow limitation. Early identification of sarcopenia and integrated interventions targeting physical activity, nutrition, and respiratory health may improve long-term outcomes in COPD.